VENLAFAXIN Mepha cpr 37.5 mg 30 pce
7680578160011
CH-57816
N06AX16
1 / 3
google
Details
- Product number
- -
- CPT
- -
- Packaging group
- -
- Unit
- -
Articles (1)
Venlafaxin-Mepha 37.5 mg, Tabletten
Tabletten
30
Official Swissmedic V2 data
Additional information from the official database
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
venlafaxinum
|
37.5 MG | Substance | Wirkstoff (Principe actif) |
|
venlafaxini hydrochloridum
|
- | Substance | WIZUS |
|
lactosum monohydricum
|
27.45 MG | Substance | HNIDK |
|
cellulosum microcristallinum
|
- | Substance | HNIDK |
|
carboxymethylamylum natricum A
|
- | Substance | HNIDK |
|
natrium
|
0.32 MG | Substance | HBESI |
|
magnesii stearas
|
- | Substance | HNIDK |
|
E 172 (flavum)
|
- | Substance | FTODK |
|
E 172 (nigrum)
|
- | Substance | FTODK |
|
E 172 (rubrum)
|
- | Substance | FTODK |
Authorization holder
Mepha Pharma AG
4051 Basel
Authorization information
- Swissmedic authorization number
- 57816
- Drug name
- Venlafaxin-Mepha, Tabletten
- Galenic form
- TAB
- ATC Code
- N06AX16
- Authorization status
- Revoked/Withdrawn
- Dispensation category
- B
- First authorization
- 09/01/2008
- Authorization expiration date
- 31/01/2026
- IT number
- 01.06.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- VENLAFAXIN Mepha cpr 37.5 mg 30 pce
- Description (DE)
- VENLAFAXIN Mepha Tabl 37.5 mg 30 Stk
- Market launch
- 09/01/2008
- Market withdrawal
- 31/01/2026
- Narcotic (BTM)
- No